BioSpace News Archive

DTx Pharma, Inc. announced today that Arthur T. Suckow, Ph.D., Chief Executive Officer, will host virtual one-on-one meetings at the 2021 BMO BioPharma Day:

Can-Fite BioPharma Ltd . today announced the Chinese National Intellectual Property Administration has issued a Notice of Allowance for its pate titled “An A3 Adenosine Receptor Ligand For Use In Treating Ectopic Fat Accumulation”.

Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual reconstitution

Neurona today announced the presentation of clinical trial plans and supporting preclinical data for its lead inhibitory neuron cell therapy candidate, NRTX-1001.

BriaCell is expanding its breast cancer platform technology into other cancers including prostate, melanoma, and non-small cell lung cancer.

Motus GI Holdings, Inc. announced today enrollment of the first patients in the European Union (EU) study of the Pure-Vu System.

BeyondSpring today announced its financial results for the first quarter ended March 31, 2021 and provided an update on recent corporate events.

Veralox Therapeutics today announced the closing of a $16.6 million Series A financing.

The Pancreatic Cancer Action Network (PanCAN), a leading pancreatic cancer advocacy organization, announced today the latest update to its novel clinical trial platform, Precision PromiseSM, with the addition of a new treatment arm by biopharmaceutical company, FibroGen, Inc.

Lipocine Inc. today announced that the Company will present at the Raymond James Human Health Innovation Conference.